skip to content

Partnering with Pharma

Who we are

“A great idea is a great idea, no matter where it comes from.”


The Corporate Business Development function, formerly known as Pharma Partnering, manages the entire business development spectrum, from identifying new partnering opportunities to executing deals and managing global alliances and assets.

>250

active global partnerships supporting innovation, research, and long-term growth

19 out of the 23

new medicines have involved a partner over the last decade

130

people worldwide focused on bringing in and managing lasting partnerships

Decorative illustration

Our approach

Our success in bringing breakthrough treatments to patients today is the result of pioneering partnerships that are built on trust, flexibility, shared values and a passion for advancing science to make a lasting contribution for people’s health.

Identify

the areas of interest

Decorative Image
Search

for the latest developments

Decorative Image
Start

in-depth conversations

Decorative illustration
Ensure

enduring partnerships

Decorative image

Where we are

130 of our colleagues around the globe are building the bridge between brilliant ideas coming from within Roche and those coming from the world around us. Our global footprint with offices in Basel, South San Francisco, Boston, Cambridge, Shanghai, Seoul and Tokyo offers speed, flexibility and accessibility.

Aerial view of the strikingly tall Roche Tower and adjacent modern office buildings in Basel, Switzerland.

Basel: Keep discovering below

Genentech campus in San Francisco USA. Modern office buildings with glass and light-colored siding, illuminated at dusk.

South San Francisco: Learn more about our Genentech Partering team

Shanghai CiCOR office building with a flat roof overhang and a large, silver DNA-like sculpture in the foreground.

Shanghai: Learn more about our Asia Partnering team

What makes Roche a unique partner for you

At Roche and Genentech, our unique company structure and culture empower us to foster meaningful, long-lasting partnerships that transform groundbreaking science into life-changing advancements for patients. We are committed to transparent collaboration, creating a dynamic ecosystem where innovation thrives. As a trusted partner, we focus on mutual growth and success, driven by a shared vision of making a positive impact on society.

17 countries

are hosting our world-class scientists across 4 continents

Global manufacturing

network and worldwide commercial presence to serve 150+ markets

#1 ranked

in “AI future readiness” amongst pharmaceutical companies

3 facts that make us a unique pharma partner:

Our capabilities strongly position us to deliver on our ambition
Graphic of our capabilities that strongly position us to deliver on our ambition

What we are looking for in a partner

What we focus on:
  • End-to-end disease areas

  • First-in-class or best-in-disease molecules

  • Novel targets or novel enabling modalities

  • Digital technologies, data sets, and advanced analytics

Assets we are looking for:
  • Answer a clear & addressable unmet need

  • Engages a "foundational target"

  • Possesses worthy pharmacologic characteristics

  • Achieves meaningful therapeutic differentiation

  • Unlocks a path to value

What we don't do:
  • Generics, biosimilars

  • OTCs

  • Animal health

Propose a partnership

If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.